Blog Posts
January 15, 2025
Top Ten Takeaways from California AG’s Healthcare AI Advisory
Related News & Insights
-
Digital Download February 19, 2025The Digital Download – Alston & Bird’s Privacy & Data Security Newsletter – February 2025Keep up with what's happening in privacy, data security, and all things cyber — from federal and state regulations for AI and the EU AI Act to sanctions on Chinese companies — from our Privacy, Cyber & Data Strategy Group.
-
Blog Posts February 3, 2025State AGs Publish Guidance on How State Laws Apply to AI
On December 24, 2024 and January 13, 2025, the Oregon Attorney General’s Office and the California Attorney General’s Office published advisories (collectively, “Advisories”) explaining how existing statutes may be used to regulate, investigate and enforce against artificial intelligence (“AI”). These Advisories serve to remind AI developers, suppliers and users of heightened regulatory scrutiny of AI, […]
The post State AGs Publish Guidance on How State Laws Apply to AI appeared first on Alston & Bird Privacy, Cyber & Data Strategy Blog.
-
Advisories February 3, 2025Consumer Protection/FTC / Antitrust Advisory | Flurry of FTC Action in the Final Days of the Khan FTC Precedes Transition to the Ferguson FTCOur Consumer Protection/FTC and Antitrust Teams highlight a spate of activity by the Federal Trade Commission (FTC) in its final days under the leadership of Lina Khan and offers a preview of what’s to come with Andrew Ferguson at the helm.
-
Healthy Byte October 16, 2024Healthy Byte | What Does the Texas Attorney General’s Recent AI Settlement Mean for AI Enforcement in Health Care?This Healthy Byte discusses a recent settlement announced by the attorney general of Texas and its implications for artificial intelligence enforcement actions in the health care industry.
-
Advisories April 22, 2024FDA/Food, Drug & Device Advisory: How the FDA Is Keeping Up with Artificial Intelligence and Machine Learning in Drug and Device Product Development and ManufacturingOur FDA/Food, Drug & Device Team examines how the Food and Drug Administration is approaching the preclearance and approval process for artificial intelligence (AI) and machine learning (ML) components in products under its purview.
Media Contact